Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Cmet

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Hepatology (Baltimore, Md.)|December 6, 2012
Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapyDavide Bitetto, Nadia Bortolotti, Edmondo Falleti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 6, 2022
Immunogenicity and safety of a third dose of anti-SARS-CoV-2 BNT16b2 vaccine in liver transplant recipientsPierluigi Toniutto, Annarosa Cussigh, Sara Cmet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 24, 2010
Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis CDavide Bitetto, Carlo Fabris, Ezio Fornasiere, et al.
Plos One|November 19, 2013
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis CEdmondo Falleti, Sara Cmet, Carlo Fabris, et al.
Journal of Clinical Immunology|June 8, 2011
Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotypeEdmondo Falleti, Davide Bitetto, Carlo Fabris, et al.
Inflammation|January 21, 2010
Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver diseaseElisabetta Fontanini, Annarosa Cussigh, Carlo Fabris, et al.
Transplantation|April 13, 2012
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor usedDavide Bitetto, Carlo Fabris, Edmondo Falleti, et al.
Journal of Hepatology|March 14, 2022
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipientsPierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Journal of Hepatology|December 15, 2010
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCCCarlo Fabris, Edmondo Falleti, Annarosa Cussigh, et al.
Disease Markers|December 21, 2020
A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow ValidationCatia Mio, Adriana Cifù, Stefania Marzinotto, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Hepatology (Baltimore, Md.)|December 6, 2012
Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapyDavide Bitetto, Nadia Bortolotti, Edmondo Falleti, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 6, 2022
Immunogenicity and safety of a third dose of anti-SARS-CoV-2 BNT16b2 vaccine in liver transplant recipientsPierluigi Toniutto, Annarosa Cussigh, Sara Cmet, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 24, 2010
Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis CDavide Bitetto, Carlo Fabris, Ezio Fornasiere, et al.
Plos One|November 19, 2013
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis CEdmondo Falleti, Sara Cmet, Carlo Fabris, et al.
Journal of Clinical Immunology|June 8, 2011
Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotypeEdmondo Falleti, Davide Bitetto, Carlo Fabris, et al.
Inflammation|January 21, 2010
Gender-related distribution of the interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in patients with end-stage liver diseaseElisabetta Fontanini, Annarosa Cussigh, Carlo Fabris, et al.
Transplantation|April 13, 2012
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor usedDavide Bitetto, Carlo Fabris, Edmondo Falleti, et al.
Journal of Hepatology|March 14, 2022
Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipientsPierluigi Toniutto, Edmondo Falleti, Sara Cmet, et al.
Journal of Hepatology|December 15, 2010
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCCCarlo Fabris, Edmondo Falleti, Annarosa Cussigh, et al.
Disease Markers|December 21, 2020
A Streamlined Approach to Rapidly Detect SARS-CoV-2 Infection Avoiding RNA Extraction: Workflow ValidationCatia Mio, Adriana Cifù, Stefania Marzinotto, et al.
Pageof 4